ARIAD PHARMACEUTICALS INC Active Patents
5 granted patents the USPTO still lists as patented, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.
- 2021-05-12: Application 17318876; Invention CRYSTALLINE FORMS OF 3-(IMIDAZO[1,2-B]PYRIDAZIN-3-YLETHYNYL)-4-METHYL-N-{4-[(4-METHYLPIPERAZIN-1-YL)METHYL]-3-(TRIFLUOROMETHYL)PHENYL}BENZAMIDE AND ITS MONO HYDROCHLORIDE SALT; Applicant ARIAD Pharmaceuticals, Inc.; Status Patented Case.
- 2021-05-12: Application 17318832; Invention CRYSTALLINE FORMS OF 3-(IMIDAZO[1,2-B]PYRIDAZIN-3-YLETHYNYL)-4-METHYL-N-{4-[(4-METHYLPIPERAZIN-1-YL)METHYL]-3-(TRIFLUOROMETHYL)PHENYL}BENZAMIDE AND ITS MONO HYDROCHLORIDE SALT; Applicant ARIAD Pharmaceuticals, Inc.; Status Patented Case.
- 2021-05-12: Application 17318772; Invention CRYSTALLINE FORMS OF 3-(IMIDAZO[1,2-B]PYRIDAZIN-3-YLETHYNYL)-4-METHYL-N-{4-[(4-METHYLPIPERAZIN-1-YL)METHYL]-3-(TRIFLUOROMETHYL)PHENYL}BENZAMIDE AND ITS MONO HYDROCHLORIDE SALT; Applicant ARIAD Pharmaceuticals, Inc.; Status Patented Case.
- 2021-05-12: Application 17318677; Invention CRYSTALLINE FORMS OF 3-(IMIDAZO[1,2-B]PYRIDAZIN-3-YLETHYNYL)-4-METHYL-N-{4-[(4-METHYLPIPERAZIN-1-YL)METHYL]-3-(TRIFLUOROMETHYL)PHENYL}BENZAMIDE AND ITS MONO HYDROCHLORIDE SALT; Applicant ARIAD Pharmaceuticals, Inc.; Status Patented Case.
| Filed | Application | Invention | Applicant | Status | Granted | Patent | Published as | Inventor name | Inventor country | Examiner |
|---|---|---|---|---|---|---|---|---|---|---|
| 2021-05-12 | 17318876 | CRYSTALLINE FORMS OF 3-(IMIDAZO[1,2-B]PYRIDAZIN-3-YLETHYNYL)-4-METHYL-N-{4-[(4-METHYLPIPERAZIN-1-YL)METHYL]-3-(TRIFLUOROMETHYL)PHENYL}BENZAMIDE AND ITS MONO HYDROCHLORIDE SALT | ARIAD Pharmaceuticals, Inc. | Patented Case | 2022-07-12 | 11384086 | US20210340149A1 | Christopher K. Murray Leonard W. Rozamus John J. Chaber Pradeep K. Sharma | United States United States United States United States | WARD, PAUL V |
| 2021-05-12 | 17318832 | CRYSTALLINE FORMS OF 3-(IMIDAZO[1,2-B]PYRIDAZIN-3-YLETHYNYL)-4-METHYL-N-{4-[(4-METHYLPIPERAZIN-1-YL)METHYL]-3-(TRIFLUOROMETHYL)PHENYL}BENZAMIDE AND ITS MONO HYDROCHLORIDE SALT | ARIAD Pharmaceuticals, Inc. | Patented Case | 2021-12-07 | 11192897 | US20210277012A1 | Christopher K. Murray Leonard W. Rozamus John J. Chaber Pradeep K. Sharma | United States United States United States United States | WARD, PAUL V |
| 2021-05-12 | 17318772 | CRYSTALLINE FORMS OF 3-(IMIDAZO[1,2-B]PYRIDAZIN-3-YLETHYNYL)-4-METHYL-N-{4-[(4-METHYLPIPERAZIN-1-YL)METHYL]-3-(TRIFLUOROMETHYL)PHENYL}BENZAMIDE AND ITS MONO HYDROCHLORIDE SALT | ARIAD Pharmaceuticals, Inc. | Patented Case | 2021-12-07 | 11192896 | US20210277011A1 | Christopher K. Murray Leonard W. Rozamus John J. Chaber Pradeep K. Sharma | United States United States United States United States | WARD, PAUL V |
| 2021-05-12 | 17318677 | CRYSTALLINE FORMS OF 3-(IMIDAZO[1,2-B]PYRIDAZIN-3-YLETHYNYL)-4-METHYL-N-{4-[(4-METHYLPIPERAZIN-1-YL)METHYL]-3-(TRIFLUOROMETHYL)PHENYL}BENZAMIDE AND ITS MONO HYDROCHLORIDE SALT | ARIAD Pharmaceuticals, Inc. | Patented Case | 2021-12-07 | 11192895 | US20210277010A1 | Christopher K. Murray Leonard W. Rozamus John J. Chaber Pradeep K. Sharma | United States United States United States United States | WARD, PAUL V |
| 2021-04-09 | 17226531 | AMINOTHIAZOLE COMPOUNDS AS C-KIT INHIBITORS | Ariad Pharmaceuticals, Inc. | Patented Case | 2023-09-12 | 11753404 | US20220033392A1 | Nicholas E. Bencivenga David C. Dalgarno Joseph M. Gozgit Wei-Sheng Huang Anna Kohlmann Feng Li Jiwei Qi William C. Shakespeare Ranny M. Thomas Yihan Wang Xiaotian Zhu | United States United States United States United States United States United States United States United States United States United States United States | SHAMEEM, GOLAM M |